Bayertz K
University of Münster, Germany.
J Med Philos. 1998 Jun;23(3):247-54. doi: 10.1076/jmep.23.3.247.2583.
In its first part, this paper seeks to make plausible (a) that molecular genetic diagnostics differs in ethically relevant ways from traditional types of medical diagnostics and (b) that the consequences of introducing this technology in broad screening-programs to detect widespread genetic diseases in a population which is not at high risk may change our understanding of health and disease in a problematic way. In its second part, the paper discusses some aspects of public control of scientific and technological innovations in the field of molecular genetic diagnostics.
在本文的第一部分，作者试图阐明以下两点：其一，分子遗传学诊断在伦理相关方面与传统医学诊断类型存在差异；其二，在广泛的筛查项目中引入该技术，以检测低风险人群中普遍存在的遗传性疾病，其后果可能会以一种有问题的方式改变我们对健康和疾病的理解。在第二部分，本文讨论了分子遗传学诊断领域中科技创新的公共控制的一些方面。
